- 英文名称
- Frovatriptan Succinate
- 分子式
- C18H23N3O5
- 分子量
- 361.39
- 中文别名
- (R)-3-(甲氨基)-2,3,4,9-四氢-1H-咔唑-6-甲酰胺琥珀酸盐; 琥珀酸夫罗曲坦; 夫罗曲普坦琥珀酸盐; (R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate; butanedioic acid,(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide; Frovatriptan succinate anhydrous; Frovatriptan (succinate); FrovatriptanSuccinate; (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate; 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1); 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1); Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1); Sb-209509ax; Vml 251; Fovatriptan succinate
- 用途
- 医药,抗偏头痛药,主要用于成人有或无先兆性偏头痛急性发作的治疗;Frovatriptan Succinate是frovatriptan的琥珀酸盐形式,作为5-HT1B/1D受体激动剂,通过激活受体发挥作用,具有高亲和力,口服生物利用度22%-30%,半衰期约26小时,主要经CYP1A2代谢。